You don't need to start with a fortune to make one on Wall Street.
News & Analysis: Teva Pharmaceutical Industries
TEVA earnings call for the period ending June 30, 2020.
These brand-name companies are big-time bargains for patient investors.
Winning stocks for the Oracle of Omaha were few during the first six months of the year.
Turnaround stories really do exist on Wall Street.
These are the stocks that might power one Fool's portfolio higher for the remainder of the year.
Emergent BioSolutions has become the go-to manufacturing partner for companies looking to develop vaccines for the coronavirus.
It's a face-off between an incredibly cheap stock and a pharmaceutical giant.
There are some serious bargains in Berkshire Hathaway's investment portfolio, as well as a few land mines.
FDA Revokes Emergency Use Authorization for Hydroxychloroquine and Chloroquine as COVID-19 Treatments
The agency found no evidence to support the theory that the antimalarial drugs touted by President Trump are effective against the coronavirus.